Cargando…
Activation of Oncogenic and Immune-Response Pathways Is Linked to Disease-Specific Survival in Merkel Cell Carcinoma
SIMPLE SUMMARY: Merkel cell carcinoma (MCC) is a rare and aggressive skin cancer. Developing targeted therapies for MCC requires increased understanding of the mechanisms driving tumor progression. In this study, we aimed to identify genes, signaling pathways, and processes that play crucial roles i...
Autores principales: | Sundqvist, Benjamin, Kilpinen, Sami, Böhling, Tom, Koljonen, Virve, Sihto, Harri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331388/ https://www.ncbi.nlm.nih.gov/pubmed/35892849 http://dx.doi.org/10.3390/cancers14153591 |
Ejemplares similares
-
LRIG1 is a positive prognostic marker in Merkel cell carcinoma and Merkel cell carcinoma expresses epithelial stem cell markers
por: Sundqvist, Benjamin, et al.
Publicado: (2021) -
ALK is frequently phosphorylated in Merkel cell carcinoma and associates with longer survival
por: Jaatinen, Jenni, et al.
Publicado: (2021) -
History of chronic inflammatory disorders increases the risk of Merkel cell carcinoma, but does not correlate with Merkel cell polyomavirus infection
por: Sahi, Helka, et al.
Publicado: (2017) -
Neurocan expression associates with better survival and viral positivity in Merkel cell carcinoma
por: Salmikangas, Marko, et al.
Publicado: (2023) -
Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma
por: Lauttia, S, et al.
Publicado: (2014)